Scientech Research’s NeuroSense Therapeutics NRSN Stock Holding History
Bought
Maintained
Sold
Other funds holding NRSN
Scientech Research's NRSN Position: Q1 2024 in Review
Scientech Research sold out of NeuroSense Therapeutics (NRSN) in Q1 2024, closing a stake of 629 shares — an estimated $10.1K sold.
Scientech Research first reported a position in NRSN in Q4 2023 and held it in 1 quarter. The position peaked at $10.1K in Q4 2023. 8 funds tracked by Wall St. Rank hold NRSN as of Q1 2024.
- Scientech Research reported no remaining NeuroSense Therapeutics position as of Q1 2024 after selling out during the quarter.
- Scientech Research sold 629 NeuroSense Therapeutics shares in Q1 2024, an estimated $10.1K.
- Scientech Research first reported a position in NeuroSense Therapeutics in Q4 2023 and held it in 1 quarter.
- Scientech Research's NeuroSense Therapeutics position peaked at $10.1K in Q4 2023.
- 8 funds tracked by Wall St. Rank held NeuroSense Therapeutics as of Q1 2024.
Based on Scientech Research's 13F filing for Q1 2024, filed 15 May 2024.